Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
4
Halozyme Therapeutics
HALO
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 10.29%5.97B | 19.33%1.61B | 5.23%1.45B | 7.47%1.47B | 9.27%1.44B | 5.45%5.41B | 1.35B | 1.38B | 1.37B | 1.32B |
Operating revenue | 10.21%5.86B | 19.34%1.58B | 4.70%1.42B | 7.61%1.45B | 9.35%1.42B | 5.69%5.32B | --1.32B | --1.35B | --1.34B | --1.3B |
Cost of revenue | 4.00%1.03B | 5.77%264.09M | 0.93%251.86M | 2.61%259.39M | 6.80%257.78M | 4.00%993.41M | 249.69M | 249.55M | 252.79M | 241.38M |
Gross profit | 11.70%4.93B | 22.43%1.34B | 6.18%1.2B | 8.57%1.21B | 9.82%1.18B | 5.79%4.42B | 1.1B | 1.13B | 1.12B | 1.08B |
Operating expense | 8.00%4.53B | 10.70%1.18B | 6.06%1.13B | 7.73%1.11B | 7.84%1.11B | 5.92%4.19B | 1.07B | 1.06B | 1.03B | 1.03B |
Selling and administrative expenses | 7.68%3.88B | 8.76%1.01B | 7.76%973.11M | 7.06%957.91M | 7.52%951.97M | 7.00%3.61B | --924.46M | --903.04M | --894.78M | --885.37M |
-General and administrative expense | 7.68%3.88B | 8.76%1.01B | 7.76%973.11M | 7.06%957.91M | 7.52%951.97M | 7.00%3.61B | --924.46M | --903.04M | --894.78M | --885.37M |
Depreciation amortization depletion | 3.87%146.29M | 5.20%37.85M | 3.62%36.77M | 4.74%36.31M | 1.87%35.35M | 1.93%140.84M | --35.98M | --35.49M | --34.67M | --34.7M |
-Depreciation and amortization | 3.87%146.29M | 5.20%37.85M | 3.62%36.77M | 4.74%36.31M | 1.87%35.35M | 1.93%140.84M | --35.98M | --35.49M | --34.67M | --34.7M |
Other operating expenses | 11.94%496.22M | 28.85%141.37M | -5.57%117.7M | 14.74%115.32M | 12.38%121.83M | -0.97%443.27M | --109.71M | --124.64M | --100.51M | --108.42M |
Operating profit | 80.90%405.76M | 501.72%157.57M | 8.26%70.38M | 18.60%101.99M | 53.03%72.11M | 3.35%224.31M | 26.19M | 65.01M | 85.99M | 47.12M |
Net non-operating interest income expense | 11.74%-65.58M | 26.68%-13.53M | 23.17%-14.63M | 2.85%-18.16M | 5.96%-17.04M | 9.44%-74.31M | -18.45M | -19.04M | -18.69M | -18.12M |
Non-operating interest expense | -11.74%65.58M | -26.68%13.53M | -23.17%14.63M | -2.85%18.16M | -5.96%17.04M | -9.44%74.31M | --18.45M | --19.04M | --18.69M | --18.12M |
Other net income (expense) | 1,318.23%22.88M | 2,026.67%23.2M | 1.32M | -415.96%-1.64M | -99.09%1.61M | 1.09M | 520K | 2K | ||
Special income (charges) | ---3.39M | --0 | ---1.49M | ---1.9M | ---- | --0 | --0 | --0 | --0 | ---- |
-Less:Other special charges | --3.39M | --0 | --1.49M | --1.9M | ---- | ---- | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 1,528.27%26.26M | 2,026.67%23.2M | --2.81M | -50.96%255K | ---- | -99.09%1.61M | --1.09M | ---- | --520K | --2K |
Income before tax | 139.46%363.06M | 1,794.71%167.25M | 24.14%57.07M | 21.18%82.18M | 89.88%55.07M | -51.32%151.61M | 8.83M | 45.97M | 67.82M | 29M |
Income tax | 179.86%63.35M | 1,448.77%26.36M | 52.35%11.06M | 25.69%15.22M | 98.54%10.36M | -50.90%22.64M | -1.95M | 7.26M | 12.11M | 5.22M |
Net income | 132.37%299.71M | 1,206.85%140.89M | 18.85%46.01M | 20.20%66.96M | 87.98%44.71M | -51.40%128.98M | 10.78M | 38.71M | 55.71M | 23.78M |
Net income continuous Operations | 132.37%299.71M | 1,206.85%140.89M | 18.85%46.01M | 20.20%66.96M | 87.98%44.71M | -51.40%128.98M | --10.78M | --38.71M | --55.71M | --23.78M |
Minority interest income | 19.04%89.37M | 78.70%26.69M | 10.15%19.68M | 6.90%24.19M | -10.01%17.67M | -1.82%75.07M | 14.93M | 17.87M | 22.63M | 19.64M |
Net income attributable to the parent company | 290.22%210.34M | 2,849.92%114.2M | 26.32%26.32M | 29.31%42.77M | 552.50%27.03M | -71.47%53.9M | -4.15M | 20.84M | 33.08M | 4.14M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 290.22%210.34M | 2,849.92%114.2M | 26.32%26.32M | 29.31%42.77M | 552.50%27.03M | -71.47%53.9M | -4.15M | 20.84M | 33.08M | 4.14M |
Basic earnings per share | 315.80%1.59 | 2,985.07%0.85 | 28.53%0.19 | 29.31%0.3034 | 552.49%0.1918 | -71.47%0.3824 | -0.0295 | 0.1478 | 0.2346 | 0.0294 |
Diluted earnings per share | 313.18%1.58 | 2,951.13%0.84 | 28.53%0.19 | 29.31%0.3034 | 552.49%0.1918 | -71.47%0.3824 | -0.0295 | 0.1478 | 0.2346 | 0.0294 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |